title: Sugammadex in a parturient with myotonic dystrophy.
authors.forename: P
authors.initials: P
authors.lastname: Stourac
authors.forename: I
authors.initials: I
authors.lastname: Krikava
authors.forename: J
authors.initials: J
authors.lastname: Seidlova
authors.forename: E
authors.initials: E
authors.lastname: Strazevska
authors.forename: M
authors.initials: M
authors.lastname: Huser
authors.forename: L
authors.initials: L
authors.lastname: Hruban
authors.forename: P
authors.initials: P
authors.lastname: Janku
authors.forename: R
authors.initials: R
authors.lastname: Gal
mesh_terms: D000328:Adult; D000732:Androstanols / Q000037:antagonists & inhibitors; D000768:Anesthesia, General; D002585:Cesarean Section; D000075202:Contraindications; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D009223:Myotonic Dystrophy / Q000150:complications*; D009388:Neostigmine; D003473:Neuromuscular Nondepolarizing Agents / Q000037:antagonists & inhibitors; D011247:Pregnancy; D011256:Pregnancy Outcome; D000077123:Rocuronium; D000077122:Sugammadex; D047408:gamma-Cyclodextrins / Q000627:therapeutic use*
chemical_list: D000732:Androstanols; D003473:Neuromuscular Nondepolarizing Agents; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D009388:Neostigmine; D000077123:Rocuronium